Find product and prescribing information about Genentech's Alecensa (alectinib), Perjeta (pertuzumab),and other Genentech oncology products
Includes information on the severity of an interaction and the type of evidence to support it. Alcohol Aldesleukin Alectinib Alemtuzumab Alendronate
NLM identifier: NCT . Alecensa (alectinib) prescribing information (2024). Genentech Inc. Available at:
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ALECENSA safely and effectively. See full prescribing information for ALECENSA. discontinue if no other potential causes of ILD/pneumonitis have been ALECENSA (alectinib) capsules, for oral use Initial U.S. Approval: 2024
alectinib or its metabolites in human milk, the effects of alectinib on the See What are the possible side effects of ALECENSA? for more information about
by E Carcereny 2024 Cited by 19The developed ALK tyrosine kinase inhibitors (TKIs), such as crizotinib, ceritinib, alectinib Highlights of prescribing information: alecensa.
Alectinib Capsule - Uses, Side Effects, and More Generic Name: alectinib. Alectinib is used to treat a certain type of lung cancer. It works by slowing or stopping the growth of cancer cells
Includes information on the severity of an interaction and the type of evidence to support it. Alcohol Aldesleukin Alectinib Alemtuzumab Alendronate
A detailed dose-reduction schedule and criteria for dose modification are included in the full prescribing information for alectinib.12. Clinical Studies. The
Comments